A simple HPLC method for simultaneous determination of lopinavir, Ritonavir and Efavirenz

Chemical and Pharmaceutical Bulletin

Volumn 51, Issue 6, 2003, Pages 715-718

  Usami, Yoshiko ^a   Oki, Tsuyoshi ^a   Nakai, Masahiko ^a   Sagisaka, Masafumi ^a   Kaneda, Tsuguhiro ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

Author keywords

Efavirenz; HPLC; Human immunodeficiency virus (HIV) 1; Lopinavir; Ritonavir; Therapeutic drug monitoring

Indexed keywords

EFAVIRENZ; LOPINAVIR; RITONAVIR;

AQUEOUS SOLUTION; ARTICLE; DRUG SCREENING; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; SOLVATION; STANDARDIZATION;

EID: 8844221359     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.51.715     Document Type: Article

References (11)

1. Clumeck N., Brun S., Sylte J., Isaacson J., Chen S., Lazzarin A., Girard P. M., Rockstroh J., Becker S., Telenti A., Bergmann F., Danner S., Ho D., Tubiana R., Carosi G., Bertz R., Hsu A., King M., Kempf D., Sun E., 8th Conference on Retroviruses and Opportunistic Infections, Chicago, on 4-8 February, 2001.
2. Corbett A. H., Lim M. L., Kashuba A. D., Ann. Pharmacother., 36, 1193-1203 (2002).
3. Kumar G. N., Rodrigues A. D., Buko A. M., Denissen J. F., J. Pharmacol. Exp. Ther., 277, 423-431 (1996).
4. Kumar G. N., Jayanti V., Lee R. D., Whittern D. N., Uchic J., Thomas S., Johnson P., Grabowski B., Sham H., Betebenner D., Kempf D. J., Denissen J. F., Drug Metab. Dispos., 27, 86-91 (1999).
5. Adkins J. C., Noble S., Drugs, 56, 1055-1064 (1998).
6. Product information, Kaletra® (lopinavir/ritonavir), Abbott Park, IL: Abbott Laboratories, 2000.
7. Marzolini C., Béguin A., Telenti A., Schreyer A., Buclin T., Biollaz J., Decosterd L. A., J. Chromatgr. B, 774, 127-140 (2002).
8. Poirier J.-M., Robidou P., Jaillon P., Ther. Drug Monit., 24, 302-309 (2002).
9. Titier K., Lagrange F., Péhourcq F., Edno-Mcheik L., Moore N., Molimard M., Ther. Drug Monit., 24, 417-424 (2002).
10. Tribut O., Arvieux C., Michelet C., Chapplain L.-M., Allain H., Bentué-Ferrer D., Ther. Drug Monit., 24, 554-562 (2002).
11. Product information, Sustiva (efavirenz), Wilmington, DE: DuPont Pharmaceuticals Company, 2001.